{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T19:38:42Z","timestamp":1767901122103,"version":"3.49.0"},"reference-count":24,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"unspecified","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIHR West Midlands Clinical Research Fellowship"},{"name":"NIHR Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2023,5,23]]},"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Correction of mitral regurgitation (MR) at the time of left ventricular assist device (LVAD) implantation remains controversial. There is conflicting evidence regarding the clinical impact of residual MR, and studies have not examined whether MR aetiology or right heart function impacts the likelihood of residual MR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This is a retrospective single-centre study of 155 consecutive patients with LVAD implantation from January 2011 to March 2020. Exclusion criteria were no MR pre-LVAD (n=8), inaccessible echocardiography (n=9), duplicate records (n=10) and concomitant mitral valve repair (n=1). Statistical analysis was performed using STATA V.16 and SPSS V.24.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Carpentier IIIb MR aetiology was associated with more severe MR pre-LVAD (severe 18\/27 (67%) vs non-severe 32\/91 (35%), p=0.004) and a higher likelihood of residual MR (8\/11 (72%) vs 30\/74 (41%), p=0.045). Of 95 patients with significant MR pre-LVAD, 15 (16%) had persistent significant MR, which was associated with higher mortality (p=0.006), post-LVAD right ventricle (RV) dilatation (10\/15 (67%) vs 28\/80 (35%), p=0.022) and RV dysfunction (14\/15 (93%) vs 35\/80 (44%), p&lt;0.001). Aside from ischaemic aetiology, other pre-LVAD parameters that were associated with significant residual MR included left ventricular end-systolic diameter (LVESD) (6.9 cm (5.7\u20137.2) vs 5.9 cm (5.5\u20136.5), p=0.043), left atrial volume index (LAVi) (78 mL\/m<jats:sup>2<\/jats:sup> (56\u201388) vs 57 mL\/m<jats:sup>2<\/jats:sup> (47\u201377), p=0.021), posterior leaflet displacement (2.5 cm (2.3\u20132.9) vs 2.3 cm (1.9\u20132.7), p=0.042) and basal right ventricular end-diastolic diameter (RVEDD) (5.1\u00b10.8 cm vs 4.5\u00b10.8 cm, p=0.010).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>LVAD therapy improves MR and tricuspid regurgitation severity in the majority, but 14% have persistent significant residual MR, associated with right ventricular dysfunction and higher long-term mortality. This may be predicted pre-LVAD by greater LVESD, RVEDD and LAVi and by ischaemic aetiology.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2022-002240","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T13:35:11Z","timestamp":1686749711000},"page":"e002240","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Predictors and clinical implications of residual mitral regurgitation following left ventricular assist device therapy"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0525-3520","authenticated-orcid":false,"given":"Harish","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"},{"name":"Institute of Cardiovascular Sciences, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengshi","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iqra","family":"Shakeel","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Morley-Smith","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"},{"name":"Harefield Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Hatch","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Bradley","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Chue","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saul G","family":"Myerson","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5687-2535","authenticated-orcid":false,"given":"Richard Paul","family":"Steeds","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"},{"name":"Institute of Cardiovascular Sciences, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sern","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"2025081611550903000_10.1.e002240.1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.athoracsur.2017.02.016","article-title":"Resolution of mitral regurgitation with left ventricular assist device support","volume":"104","author":"Goodwin","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"2025081611550903000_10.1.e002240.2","first-page":"81","article-title":"Significance of residual mitral regurgitation after continuous flow left ventricular assist device implantation","volume":"5","author":"Kassis","year":"2017","journal-title":"JACC: Heart Failure"},{"key":"2025081611550903000_10.1.e002240.3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.healun.2013.06.004","article-title":"Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation","volume":"32","author":"Kitada","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"2025081611550903000_10.1.e002240.4","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.jtcvs.2018.12.071","article-title":"Mitral valve repair for severe mitral valve regurgitation during left ventricular assist device implantation","volume":"157","author":"Pawale","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025081611550903000_10.1.e002240.5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MAT.0b013e31829be026","article-title":"Mitral valve repair at the time of continuous-flow left ventricular assist device implantation confers meaningful decrement in pulmonary vascular resistance","volume":"59","author":"Taghavi","year":"2013","journal-title":"ASAIO J"},{"key":"2025081611550903000_10.1.e002240.6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/icvts\/ivx223","article-title":"Impact of concomitant mitral valve repair for severe mitral regurgitation at the time of continuous-flow left ventricular assist device insertion","volume":"25","author":"Sandoval","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2025081611550903000_10.1.e002240.7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.athoracsur.2016.06.078","article-title":"Surgically corrected mitral regurgitation during left ventricular assist device implantation is associated with low recurrence rate and improved Midterm survival","volume":"103","author":"Tanaka","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"2025081611550903000_10.1.e002240.8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.healun.2017.09.016","article-title":"Concomitant mitral valve procedures in patients undergoing implantation of continuous-flow left ventricular assist devices: an INTERMACS database analysis","volume":"37","author":"Robertson","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"2025081611550903000_10.1.e002240.9","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.healun.2014.11.023","article-title":"Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation","volume":"34","author":"Stulak","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"2025081611550903000_10.1.e002240.10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/ejcts\/ezz098","article-title":"2019 EACTS expert consensus on long-term mechanical circulatory support","volume":"56","author":"Potapov","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025081611550903000_10.1.e002240.11","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0b013e31826e4267"},{"key":"2025081611550903000_10.1.e002240.12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.healun.2020.03.003","article-title":"Impact of left ventricular assist device implantation on mitral regurgitation: an analysis from the MOMENTUM 3 trial","volume":"39","author":"Kanwar","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2025081611550903000_10.1.e002240.13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jtcvs.2019.03.089","article-title":"Right ventricular function and residual mitral regurgitation after left ventricular assist device implantation determines the incidence of right heart failure","volume":"159","author":"Tang","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025081611550903000_10.1.e002240.14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008813","article-title":"Prevalence, predictors, and prognostic value of residual tricuspid regurgitation in patients with left ventricular assist device","volume":"7","author":"Nakanishi","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2025081611550903000_10.1.e002240.15","first-page":"141","article-title":"Durability and efficacy of tricuspid valve repair in patients undergoing left ventricular assist device implantation","volume":"8","author":"Barac","year":"2020","journal-title":"JACC: Heart Failure"},{"key":"2025081611550903000_10.1.e002240.16","doi-asserted-by":"crossref","first-page":"G9","DOI":"10.1530\/ERP-14-0079","article-title":"A minimum dataset for a standard adult transthoracic echocardiogram: a guideline protocol from the British society of echocardiography","volume":"2","author":"Wharton","year":"2015","journal-title":"Echo Res Pract"},{"key":"2025081611550903000_10.1.e002240.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000503"},{"key":"2025081611550903000_10.1.e002240.18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx391"},{"key":"2025081611550903000_10.1.e002240.19","doi-asserted-by":"publisher","DOI":"10.1093\/ejechocard\/jeq031"},{"key":"2025081611550903000_10.1.e002240.20","doi-asserted-by":"crossref","first-page":"G11","DOI":"10.1530\/ERP-17-0071","article-title":"Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography","volume":"5","author":"Augustine","year":"2018","journal-title":"Echo Res Pract"},{"key":"2025081611550903000_10.1.e002240.21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/clc.23879","article-title":"Stage-based approach to predict left ventricular reverse remodeling after mitral repair","volume":"45","author":"Hibino","year":"2022","journal-title":"Clin Cardiol"},{"key":"2025081611550903000_10.1.e002240.22","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1053\/j.jvca.2018.11.013","article-title":"Assessment of left ventricular reverse remodeling by cardiac MRI in patients undergoing repair surgery for severe aortic or mitral regurgitation","volume":"33","author":"Seldrum","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025081611550903000_10.1.e002240.23","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90151-1"},{"key":"2025081611550903000_10.1.e002240.24","doi-asserted-by":"crossref","DOI":"10.1530\/ERP-19-0050e","article-title":"Normal reference intervals for cardiac dimensions and function for use in Echocardiographic practice: a guideline from the British society of echocardiography","volume":"7","author":"Harkness","year":"2020","journal-title":"Echo Res Pract"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2022-002240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T18:55:21Z","timestamp":1755370521000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2022-002240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,6,14]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1136\/openhrt-2022-002240"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2022-002240","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}